Targeting tumours with genetically enhanced T lymphocytes

被引：412

作者：

Sadelain, M

Rivière, I

Brentjens, R

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA

[2] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA

来源：

NATURE REVIEWS CANCER | 2003年 / 3卷 / 01期

关键词：

D O I：

10.1038/nrc971

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The genetic modification of T lymphocytes is an important approach to investigating normal T-cell biology and to increasing antitumour immunity. A number of genetic strategies aim to increase the recognition of tumour antigens, enhance antitumour activities and prevent T-cell malfunction. T cells can also be engineered to increase safety, as well as to express markers that can be tracked by non-invasive imaging technologies. Genetically modified T cells are therefore proving to be of great value for basic immunology and experimental immunotherapy.

引用

页码：35 / 45

页数：11

共 134 条

[1] Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2
Agrawal, B
Krantz, MJ
Reddish, MA
Longenecker, BM
[J]. NATURE MEDICINE, 1998, 4 (01) : 43 - 49
[2] Altenschmidt U, 1996, CLIN CANCER RES, V2, P1001
[3] Altenschmidt U, 1997, J IMMUNOL, V159, P5509
[4] Antigen-specific targeting of CD28-mediated T cell co-stimulation using chimeric single-chain antibody variable fragment-CD28 receptors
AlvarezVallina, L
Hawkins, RE
[J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (10) : 2304 - 2309
[5] Coupling CD28 co-stimulation to immunoglobulin T-cell receptor molecules: The dynamics of T-cell proliferation and death
Beecham, EJ
Ma, QZ
Ripley, R
Junghans, RP
[J]. JOURNAL OF IMMUNOTHERAPY, 2000, 23 (06): : 631 - 642
[6] Dynamics of tumor cell killing by human T lymphocytes armed with an anti-carcinoembryonic antigen chimeric immunoglobulin T-cell receptor
Beecham, EJ
Ortiz-Pujols, S
Junghans, RP
[J]. JOURNAL OF IMMUNOTHERAPY, 2000, 23 (03): : 332 - 343
[7] In vivo imaging of gene delivery and expression
Bogdanov, Alexei, Jr.
Weissleder, Ralph
[J]. TRENDS IN BIOTECHNOLOGY, 2002, 20 (08) : S11 - S18
[8] CD28 COSTIMULATION CAN PROMOTE T-CELL SURVIVAL BY ENHANCING THE EXPRESSION OF BCL-X(L)
BOISE, LH
MINN, AJ
NOEL, PJ
JUNE, CH
ACCAVITTI, MA
LINDSTEN, T
THOMPSON, CB
[J]. IMMUNITY, 1995, 3 (01) : 87 - 98
[9] Adapting a transforming growth factor β-related tumor protection strategy to enhance antitumor immunity
Bollard, CM
Rössig, C
Calonge, MJ
Huls, MH
Wagner, HJ
Massague, J
Brenner, MK
Heslop, HE
Rooney, CM
[J]. BLOOD, 2002, 99 (09) : 3179 - 3187
[10] Tumor antigens
Boon, T
Old, LJ
[J]. CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (05) : 681 - 683

← 1 2 3 4 5 6 7 8 9 10 →